144 related articles for article (PubMed ID: 8109900)
21. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease.
Banati RB; Daniel SE; Blunt SB
Mov Disord; 1998 Mar; 13(2):221-7. PubMed ID: 9539333
[TBL] [Abstract][Full Text] [Related]
22. Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?
Chu Y; Kordower JH
Neurobiol Dis; 2007 Jan; 25(1):134-49. PubMed ID: 17055279
[TBL] [Abstract][Full Text] [Related]
23. Low numbers and no loss of melanized nigral neurons with increasing age in normal human brains from India.
Muthane U; Yasha TC; Shankar SK
Ann Neurol; 1998 Mar; 43(3):283-7. PubMed ID: 9506543
[TBL] [Abstract][Full Text] [Related]
24. Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata.
Hardman CD; Halliday GM; McRitchie DA; Cartwright HR; Morris JG
Exp Neurol; 1997 Mar; 144(1):183-92. PubMed ID: 9126169
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of alpha-ketoglutarate dehydrogenase complex promotes cytochrome c release from mitochondria, caspase-3 activation, and necrotic cell death.
Huang HM; Ou HC; Xu H; Chen HL; Fowler C; Gibson GE
J Neurosci Res; 2003 Oct; 74(2):309-17. PubMed ID: 14515360
[TBL] [Abstract][Full Text] [Related]
26. Abnormality of the alpha-ketoglutarate dehydrogenase complex in fibroblasts from familial Alzheimer's disease.
Sheu KF; Cooper AJ; Koike K; Koike M; Lindsay JG; Blass JP
Ann Neurol; 1994 Mar; 35(3):312-8. PubMed ID: 8122883
[TBL] [Abstract][Full Text] [Related]
27. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
[TBL] [Abstract][Full Text] [Related]
28. Localization of CKII beta subunits in Lewy bodies of Parkinson's disease.
Ryu MY; Kim DW; Arima K; Mouradian MM; Kim SU; Lee G
J Neurol Sci; 2008 Mar; 266(1-2):9-12. PubMed ID: 17884098
[TBL] [Abstract][Full Text] [Related]
29. Reduced NADH coenzyme Q dehydrogenase activity in platelets of Parkinson's disease, but not Parkinson plus patients, from an Indian population.
Varghese M; Pandey M; Samanta A; Gangopadhyay PK; Mohanakumar KP
J Neurol Sci; 2009 Apr; 279(1-2):39-42. PubMed ID: 19176229
[TBL] [Abstract][Full Text] [Related]
30. Brain protein and alpha-ketoglutarate dehydrogenase complex activity in Alzheimer's disease.
Mastrogiacoma F; Lindsay JG; Bettendorff L; Rice J; Kish SJ
Ann Neurol; 1996 May; 39(5):592-8. PubMed ID: 8619544
[TBL] [Abstract][Full Text] [Related]
31. Independent modulation of the activity of alpha-ketoglutarate dehydrogenase complex by Ca2+ and Mg2+.
Panov A; Scarpa A
Biochemistry; 1996 Jan; 35(2):427-32. PubMed ID: 8555212
[TBL] [Abstract][Full Text] [Related]
32. Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions.
Chu Y; Dodiya H; Aebischer P; Olanow CW; Kordower JH
Neurobiol Dis; 2009 Sep; 35(3):385-98. PubMed ID: 19505575
[TBL] [Abstract][Full Text] [Related]
33. Presymptomatic detection of Parkinson's disease.
Jenner P
J Neural Transm Suppl; 1993; 40():23-36. PubMed ID: 8294898
[TBL] [Abstract][Full Text] [Related]
34. Morphological alterations of the synapses in the locus coeruleus in Parkinson's disease.
Baloyannis SJ; Costa V; Baloyannis IS
J Neurol Sci; 2006 Oct; 248(1-2):35-41. PubMed ID: 16753180
[TBL] [Abstract][Full Text] [Related]
35. Absence of age-related changes in nigral dopaminergic neurons of Asian Indians: relevance to lower incidence of Parkinson's disease.
Alladi PA; Mahadevan A; Yasha TC; Raju TR; Shankar SK; Muthane U
Neuroscience; 2009 Mar; 159(1):236-45. PubMed ID: 19135503
[TBL] [Abstract][Full Text] [Related]
36. Oxidative metabolites of 5-S-cysteinyldopamine inhibit the pyruvate dehydrogenase complex.
Li H; Dryhurst G
J Neural Transm (Vienna); 2001; 108(12):1363-74. PubMed ID: 11810401
[TBL] [Abstract][Full Text] [Related]
37. Oxidative metabolites of 5-S-cysteinyldopamine inhibit the alpha-ketoglutarate dehydrogenase complex: possible relevance to the pathogenesis of Parkinson's disease.
Shen XM; Li H; Dryhurst G
J Neural Transm (Vienna); 2000; 107(8-9):959-78. PubMed ID: 11041275
[TBL] [Abstract][Full Text] [Related]
38. Selective loss of KGDHC-enriched neurons in Alzheimer temporal cortex: does mitochondrial variation contribute to selective vulnerability?
Ko LW; Sheu KF; Thaler HT; Markesbery WR; Blass JP
J Mol Neurosci; 2001 Dec; 17(3):361-9. PubMed ID: 11859932
[TBL] [Abstract][Full Text] [Related]
39. The alpha-ketoglutarate dehydrogenase complex in neurodegeneration.
Gibson GE; Park LC; Sheu KF; Blass JP; Calingasan NY
Neurochem Int; 2000 Feb; 36(2):97-112. PubMed ID: 10676873
[TBL] [Abstract][Full Text] [Related]
40. Exclusive neuronal detection of KGDHC-specific subunits in the adult human brain cortex despite pancellular protein lysine succinylation.
Dobolyi A; Bago A; Palkovits M; Nemeria NS; Jordan F; Doczi J; Ambrus A; Adam-Vizi V; Chinopoulos C
Brain Struct Funct; 2020 Mar; 225(2):639-667. PubMed ID: 31982949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
